Annual CFF
$62.18 M
+$28.86 M+86.62%
31 December 2023
Summary:
Carisma Therapeutics annual cash flow from financing activities is currently $62.18 million, with the most recent change of +$28.86 million (+86.62%) on 31 December 2023. During the last 3 years, it has fallen by -$10.08 million (-13.95%). CARM annual CFF is now -13.95% below its all-time high of $72.26 million, reached on 01 December 2020.CARM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$461.00 K
-$534.00 K-731.51%
30 September 2024
Summary:
Carisma Therapeutics quarterly cash flow from financing activities is currently -$461.00 thousand, with the most recent change of -$534.00 thousand (-731.51%) on 30 September 2024. Over the past year, it has increased by +$1.57 million (+77.32%). CARM quarterly CFF is now -100.68% below its all-time high of $67.74 million, reached on 31 March 2023.CARM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$1.06 M
+$1.57 M+310.06%
30 September 2024
Summary:
Carisma Therapeutics TTM cash flow from financing activities is currently $1.06 million, with the most recent change of +$1.57 million (+310.06%) on 30 September 2024. Over the past year, it has dropped by -$59.56 million (-98.24%). CARM TTM CFF is now -98.39% below its all-time high of $66.06 million, reached on 31 March 2023.CARM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARM Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +86.6% | +77.3% | -98.2% |
| 3 y3 years | -13.9% | - | - |
| 5 y5 years | - | - | - |
CARM Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -13.9% | +289.6% | -100.7% | +87.3% | -98.4% | +125.3% |
| 5 y | 5 years | -13.9% | +289.6% | -100.7% | +87.3% | -98.4% | +125.3% |
| alltime | all time | -13.9% | +289.6% | -100.7% | +87.3% | -98.4% | +125.3% |
Carisma Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$461.00 K(-731.5%) | $1.06 M(-310.1%) |
| June 2024 | - | $73.00 K(-94.6%) | -$507.00 K(-88.0%) |
| Mar 2024 | - | $1.35 M(+1238.6%) | -$4.21 M(-106.8%) |
| Dec 2023 | $62.18 M | $101.00 K(-105.0%) | $62.18 M(+2.6%) |
| Sept 2023 | - | -$2.03 M(-44.0%) | $60.62 M(-2.9%) |
| June 2023 | - | -$3.63 M(-105.4%) | $62.45 M(-5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $67.74 M(-4746.2%) | $66.06 M(+98.3%) |
| Dec 2022 | $33.32 M(+108.7%) | -$1.46 M(+607.8%) | $33.32 M(-4.2%) |
| Sept 2022 | - | -$206.00 K(+1111.8%) | $34.78 M(-0.6%) |
| June 2022 | - | -$17.00 K(-100.0%) | $34.98 M(-0.0%) |
| Mar 2022 | - | $35.00 M | $35.00 M |
| Dec 2021 | $15.96 M(-77.9%) | - | - |
| Dec 2020 | $72.26 M | - | - |
FAQ
- What is Carisma Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Carisma Therapeutics?
- What is Carisma Therapeutics annual CFF year-on-year change?
- What is Carisma Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Carisma Therapeutics?
- What is Carisma Therapeutics quarterly CFF year-on-year change?
- What is Carisma Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Carisma Therapeutics?
- What is Carisma Therapeutics TTM CFF year-on-year change?
What is Carisma Therapeutics annual cash flow from financing activities?
The current annual CFF of CARM is $62.18 M
What is the all time high annual CFF for Carisma Therapeutics?
Carisma Therapeutics all-time high annual cash flow from financing activities is $72.26 M
What is Carisma Therapeutics annual CFF year-on-year change?
Over the past year, CARM annual cash flow from financing activities has changed by +$28.86 M (+86.62%)
What is Carisma Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CARM is -$461.00 K
What is the all time high quarterly CFF for Carisma Therapeutics?
Carisma Therapeutics all-time high quarterly cash flow from financing activities is $67.74 M
What is Carisma Therapeutics quarterly CFF year-on-year change?
Over the past year, CARM quarterly cash flow from financing activities has changed by +$1.57 M (+77.32%)
What is Carisma Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CARM is $1.06 M
What is the all time high TTM CFF for Carisma Therapeutics?
Carisma Therapeutics all-time high TTM cash flow from financing activities is $66.06 M
What is Carisma Therapeutics TTM CFF year-on-year change?
Over the past year, CARM TTM cash flow from financing activities has changed by -$59.56 M (-98.24%)